Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-PLEX phase 3 study for prevention of incisional surgical site infection after colorectal surgery
2020-003617-36Phase 3Active
- Sponsor
- PolyPid Ltd.
- Start
- Oct 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in surgical site infection (SSI) comparing D-PLEX + standard of care with Standard of care control (2 arms). Primary endpoint: Abdominal target incisional infection rate within 30 days. Started Oct 2020; status: active.
02
Drugs
D-PLEX100
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2020-003617-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003617-36.